Target intelligence / Profile preview

NADH:ubiquinone oxidoreductase subunit A3 pseudogene 1 (NDUFA3P1)

Target: NDUFA3P1
Molecular classification: Pseudogene

Overview

NDUFA3P1 (NADH:ubiquinone oxidoreductase subunit A3 pseudogene 1) is a processed pseudogene in the human genome. It is classified as a pseudogene because it does not encode a functional protein product, and is not known to have a direct biological or therapeutic function[3][6][8]. Pseudogenes like NDUFA3P1 may have roles in genomic evolution or regulation, but are not typical drug or therapeutic targets[10].

Other names: NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3 pseudogene 1

Biological functions

Other

Disease associations

Other

Beyond the preview

Go deeper on NADH:ubiquinone oxidoreductase subunit A3 pseudogene 1 (NDUFA3P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit A3 pseudogene 1 (NDUFA3P1).

Explore the full profile